+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biobanks Market by Type, Component, Sample Type, Application, End User, Ownership - Global Forecast to 2030- Product Image
Biobanks Market by Type, Component, Sample Type, Application, End User, Ownership - Global Forecast to 2030- Product Image
Sale

Biobanks Market by Type, Component, Sample Type, Application, End User, Ownership - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082867
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biobanks market is undergoing rapid transformation, shaped by technological advancements, evolving regulations, and the increasing need for high-quality biospecimens in precision medicine and research. Senior decision-makers must navigate a complex, innovation-driven landscape where strategic adaptations define future success.

Market Snapshot: Biobanks Market Size and Growth

The biobanks market grew from USD 115.43 billion in 2024 to USD 130.56 billion in 2025. It is expected to continue expanding at a CAGR of 13.49%, reaching USD 246.72 billion by 2030.

Scope & Segmentation

This comprehensive analysis dissects the biobanks market through key segments, technologies, and regional variations.

  • Type: Disease-oriented, genomic-based, population-based, and virtual biobanks each cater to distinct research and healthcare initiatives.
  • Component: Consumables, equipment (alarms and monitoring systems, incubators and centrifuges, temperature control systems), and services (data management, sample analysis, storage and processing, transport) together ensure robust biobanking operations.
  • Sample Type: Blood derivatives, cell lines, nucleic acids, and tissues enable diverse applications in molecular diagnostics and research.
  • Application: Clinical diagnostics, personalized medicine, research, drug development, and gene editing support a spectrum of medical and bioscience advancements.
  • End User: Academic institutions, biotechnology companies, hospitals, and pharmaceutical companies are primary stakeholders in biobank utilization.
  • Ownership: Academic biobanks, commercial biobanks, and government biobanks offer varying governance and funding frameworks.
  • Geography: The analysis covers the Americas, Europe, Middle East & Africa, and Asia-Pacific, recognizing region-specific infrastructure, regulation, and demand drivers.

Key Takeaways: Strategic Insights for Biobanks Market Leaders

  • The integration of advanced automation and digital platforms is minimizing manual errors and streamlining specimen management, which enhances research efficiency.
  • Collaborative partnerships among public institutions, private enterprise, and global technology vendors are fostering multi-omics studies and genomic collection initiatives.
  • Virtual biobank technology is enabling decentralized data sharing while protecting privacy, expanding research capabilities beyond traditional geographic constraints.
  • Evolving ethical and regulatory policies are shaping new standards for specimen consent, privacy, and cross-border sample management, demanding adaptive governance.
  • Strategic alliances and bundled service offerings set market leaders apart, enabling integrated sample management, analytical services, and digital data sharing.
  • Investment in regional infrastructure and supply chain optimization is driving resilience and responsiveness, with tailored approaches for emerging and established markets.

Tariff Impact on Biobank Supply Chains

The introduction of cumulative United States tariffs in 2025 has increased procurement costs for biobank equipment and consumables. Senior leaders are responding by reassessing sourcing strategies, increasing domestic manufacturing, and consolidating shipments to offset logistics expenses. These tariffs have stimulated local assembly and dual sourcing, strengthening supply chain resilience and encouraging innovation in inventory management across international operations.

Methodology & Data Sources

This report relies on a multi-stage research methodology, weaving primary interviews with industry experts and secondary analysis of scientific publications, trade databases, and regulatory filings. Rigorous data triangulation supports thematic analysis and validates findings for actionable strategic intelligence.

Why This Report Matters

  • Enables senior leaders to align technology, operations, and supply chain strategies with market shifts and regulatory demands.
  • Provides segmentation intelligence to support investment planning, strategic partnerships, and targeted market entry across regions and applications.
  • Delivers insights to foster resilient, innovative, and collaborative biobank ecosystems ready to meet shifting industry, research, and clinical needs.

Conclusion

The biobanks market is at the forefront of biomedical innovation, underpinned by evolving technology, adaptive governance, and resilient supply strategies. Organizations that capitalize on segmentation intelligence and strategic alliances will position themselves for sustained impact and growth.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biobanks Market, by Type
8.1. Introduction
8.2. Disease-Oriented
8.3. Genomic-Based
8.4. Population-Based
8.5. Virtual
9. Biobanks Market, by Component
9.1. Introduction
9.2. Consumables
9.3. Equipment
9.3.1. Alarms & Monitoring Systems
9.3.2. Incubators & Centrifuges
9.3.3. Temperature Control Systems
9.4. Services
9.4.1. Data Management
9.4.2. Sample Analysis
9.4.3. Storage & Processing
9.4.4. Transpost
10. Biobanks Market, by Sample Type
10.1. Introduction
10.2. Blood Derivatives
10.3. Cell Lines
10.4. Nucleic Acid
10.5. Tissues
11. Biobanks Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.3. Personalized Medicine
11.4. Research
11.5. Therapeutics
11.5.1. Drug Development
11.5.2. Gene Editing
12. Biobanks Market, by End User
12.1. Introduction
12.2. Academic Institutions
12.3. Biotechnology Companies
12.4. Hospitals
12.5. Pharmaceutical Companies
13. Biobanks Market, by Ownership
13.1. Introduction
13.2. Academic Biobanks
13.3. Commercial Biobanks
13.4. Government Biobanks
14. Americas Biobanks Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biobanks Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biobanks Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Acorn Biolabs, Inc.
17.3.2. AMS Biotechnology (Europe) Limited
17.3.3. Artizan Biosciences, Inc.
17.3.4. ASKION GmbH
17.3.5. Avantor, Inc.
17.3.6. Bay Biosciences LLC
17.3.7. Beckman Coulter, Inc. by Danaher Corporation
17.3.8. Becton, Dickinson and Company
17.3.9. BioIVT LLC
17.3.10. BioKryo by L’AIR LIQUIDE S.A.
17.3.11. BioLife Solutions Inc.
17.3.12. BocaBio
17.3.13. Charles River Laboratories International, Inc.
17.3.14. Cryoport Systems, LLC
17.3.15. CTIBiotech
17.3.16. Cureline, Inc.
17.3.17. Firalis Group
17.3.18. Greiner AG
17.3.19. Hamilton Company
17.3.20. LVL Technologies GmbH & Co. KG
17.3.21. Merck KGaA
17.3.22. Micronic Holding B.V.
17.3.23. ProteoGenex, Inc.
17.3.24. Provia Laboratories, LLC
17.3.25. Qiagen N.V.
17.3.26. Shanghai Outdo Biotech Co. Ltd
17.3.27. Taylor-Wharton
17.3.28. Tecan Trading AG
17.3.29. Thermo Fisher Scientific Inc.
17.3.30. UK Biobank Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOBANKS MARKET MULTI-CURRENCY
FIGURE 2. BIOBANKS MARKET MULTI-LANGUAGE
FIGURE 3. BIOBANKS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY ALARMS & MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPOST, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOBANKS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOBANKS MARKET SIZE, BY COMMERCIAL BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOBANKS MARKET SIZE, BY GOVERNMENT BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 69. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 70. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 73. CANADA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 124. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 130. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 133. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 134. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. FRANCE BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 148. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 151. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 152. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 153. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 155. ITALY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. ITALY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 157. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 160. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 193. DENMARK BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. DENMARK BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 195. DENMARK BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 196. DENMARK BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. DENMARK BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 198. DENMARK BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. DENMARK BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 200. DENMARK BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. DENMARK BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 211. QATAR BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. QATAR BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. QATAR BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 214. QATAR BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. QATAR BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. QATAR BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. QATAR BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 218. QATAR BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 220. FINLAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 222. FINLAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 223. FINLAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 227. FINLAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. FINLAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 247. EGYPT BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 249. EGYPT BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 250. EGYPT BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 251. EGYPT BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 252. EGYPT BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. EGYPT BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 254. EGYPT BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. EGYPT BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 256. TURKEY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. TURKEY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 258. TURKEY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 259. TURKEY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 274. NORWAY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 276. NORWAY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 277. NORWAY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 278. NORWAY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 283. POLAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. POLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 285. POLAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 286. POLAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 287. POLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 288. POLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. POLAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 290. POLAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. POLAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 311. CHINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 313. CHINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 314. CHINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 315. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 316. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. CHINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 318. CHINA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. CHINA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 320. INDIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 322. INDIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 323. INDIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 324. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 325. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. INDIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 327. INDIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. INDIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 329. JAPAN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 330. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 331. JAPAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 332. JAPAN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 333. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 334. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. JAPAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 336. JAPAN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. JAPAN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 343. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. AUSTRALIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 345. AUSTRALIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 346. AUSTRALIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 352. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. SOUTH KOREA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 354. SOUTH KOREA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. SOUTH KOREA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 361. INDONESIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 362. INDONESIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 363. INDONESIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 364. INDONESIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 365. THAILAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 366. THAILAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 367. THAILAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 368. THAILAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 369. THAILAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 370. THAILAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 371. THAILAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 372. THAILAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 373. THAILAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 374. PHILIPPINES BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 375. PHILIPPINES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 376. PHILIPPINES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 377. PHILIPPINES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 378. PHILIPPINES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 379. PHILIPPINES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 380. PHILIPPINES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 381. PHILIPPINES BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 382. PHILIPPINES BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 383. MALAYSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 384. MALAYSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 385. MALAYSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 386. MALAYSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 387. MALAYSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 388. MALAYSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 389. MALAYSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 390. MALAYSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 391. MALAYSIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 392. SINGAPORE BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 393. SINGAPORE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 394. SINGAPORE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 395. SINGAPORE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 396. SINGAPORE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 397. SINGAPORE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 398. SINGAPORE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 399. SINGAPORE BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 400. SINGAPORE BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 401. VIETNAM BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 402. VIETNAM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 403. VIETNAM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biobanks market report include:
  • Acorn Biolabs, Inc.
  • AMS Biotechnology (Europe) Limited
  • Artizan Biosciences, Inc.
  • ASKION GmbH
  • Avantor, Inc.
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioIVT LLC
  • BioKryo by L’AIR LIQUIDE S.A.
  • BioLife Solutions Inc.
  • BocaBio
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech
  • Cureline, Inc.
  • Firalis Group
  • Greiner AG
  • Hamilton Company
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA
  • Micronic Holding B.V.
  • ProteoGenex, Inc.
  • Provia Laboratories, LLC
  • Qiagen N.V.
  • Shanghai Outdo Biotech Co. Ltd
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 130.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 246.72 Billion
Compound Annual Growth Rate13.4%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Biobanks - Global Strategic Business Report - Product Image

Biobanks - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033 - Product Image

Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032 - Product Image

Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
2025 Global Forecast for Biobank Sample Management And Storage System Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Biobank Sample Management And Storage System Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Biobank Market

The Biobank market is a subset of the biotechnology industry that focuses on the collection, storage, and distribution of biological samples for research purposes. These samples can include human tissue, blood, and other bodily fluids, as well as plant and animal tissue. The biobank market is driven by the need for high-quality biological samples for research and development in the biotechnology industry. Biobanks are used to store and distribute biological samples for a variety of research purposes, including drug discovery, diagnostics, and personalized medicine. They are also used to store and distribute samples for clinical trials and epidemiological studies. The biobank market is highly competitive, with a number of companies offering services such as sample collection, storage, and distribution. Some of the major players in the market include Thermo Fisher Scientific, Qiagen, BioStorage Technologies, and Brooks Life Sciences. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.